News & enforcement.
The regulatory actions, lawsuits, and industry shifts moving the research-peptide market. Every item links to its source and is tagged by how much weight it deserves — a primary FDA or court document is not the same as a forum rumor, and we mark which is which.
17 records
Source
Topic
- Official recordOct 1, 2026· FDA MedWatch
Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
Primary government, court, or regulatory document
- Official recordSep 29, 2026· U.S. Food & Drug Administration
FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme
The U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals.
- Official recordSep 13, 2026· FDA MedWatch
Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels
FOR IMMEDIATE RELEASE – 9/9/2026 – Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer’s Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be compounded with a Glutathione API containing elevated endot
- Official recordAug 19, 2026· FDA Recalls, Market Withdrawals & Safety Alerts
Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
FOR IMMEDIATE RELEASE – August 19, 2026 – Houston, Texas, Optimal Balance Pharmacy is voluntarily recalling one lot of Compounded Glutathione 200 MG/ML 30 ML Multi-Dose Vials to the patient level. The product is being recalled because pharmacy testing identified elevated bacterial endotoxin levels.
- Official recordAug 5, 2026· FDA MedWatch
Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
FOR IMMEDIATE RELEASE – August 5, 2026 – Austin, Texas, Victory Medical Center Pharmacy is voluntarily recalling certain lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials to the patient level. The product is being recalled because pharmacy testing identified elevated bacterial endotoxin leve
Earlier, on the record
Peptide Sciences shuts down — largest U.S. grey-market peptide vendor exits
Industry blogMar 6, 2026Science.bio announces voluntary closure
Industry blogJan 27, 2026United States v. Matthew Kawa et al. — Paradigm Peptides guilty plea
Paradigm PeptidesOfficial recordDec 10, 2025
Showing 10 of 17